Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort.

Mair, M J; Mitterer, M; Buratti, T; Berchtold, L; Fong, D; Preusser, M

Mair, M J; Mitterer, M; Buratti, T; Berchtold, L; Fong, D; Preusser, M.

Afiliação

Mair MJ; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: https://twitter.com/MedUni_Wien.
Mitterer M; Hemato-Oncological Day Hospital Unit, Franz Tappeiner Hospital, Meran/Merano, Italy.
Buratti T; Hemato-Oncological Day Hospital Unit, Franz Tappeiner Hospital, Meran/Merano, Italy.
Berchtold L; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Fong D; Hemato-Oncological Day Hospital Unit, Franz Tappeiner Hospital, Meran/Merano, Italy.
Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: matthias.preusser@meduniwien.ac.at.

ESMO Open ; 8(3): 101559, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37196399

Assuntos

COVID-19; Humanos; COVID-19/epidemiologia; COVID-19/prevenção & controle; SARS-CoV-2; Estudos de Coortes; Vacinação; Infecções Irruptivas

Palavras-chave

COVID-19; SARS-CoV-2; cancer; pandemic; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google